Global News

Procurar notícias por assunto

Press release: Diaverum grows its presence in Brazil by acquiring three dialysis centers

Press release: Diaverum grows its presence in Brazil by acquiring three dialysis centers

LUND / SAO PAULO, 21 November, 2018 - Diaverum, one of the world’s leading renal care service providers, is announcing its acquisition of three dialysis centers in Brazil, currently treating more than 900 patients. With this addition, Diaverum is now treating close to 2,000 patients in Brazil.

Diaverum supports World Diabetes Day by raising awareness about the link between diabetes and kidney disease

Diaverum supports World Diabetes Day by raising awareness about the link between diabetes and kidney disease

Diabetes is a main risk factor for the development of kidney disease and early detection is key to stop the progression of the disease. Diaverum supports International Diabetes Day by raising awareness about the effects of diabetes on kidneys.

Press release: Diaverum enters Macedonia by acquiring PZU Diamed Macedonia

Press release: Diaverum enters Macedonia by acquiring PZU Diamed Macedonia

Lund, Sweden, November 1st , 2018 - Diaverum, one of the leading renal care providers worldwide, announces the acquisition of PZU Diamed Macedonia which operates 9 dialysis centres and cares for more than 670 patients in Macedonia.

Press release: Diaverum appoints new President & Chief Executive Officer

Diaverum announces the appointment of Dimitris Moulavasilis as the new President & Chief Executive Officer. He succeeds Dag Andersson who is leaving the position as CEO after eleven years. Dag Andersson will continue to work for the company as senior advisor and Chairman of Diaverum Arabia.

Diaverum’s CEO and President, Dag Andersson, speaks at Healthcare Innovation Congress in Riyadh

Diaverum’s CEO and President, Dag Andersson, attended the Healthcare Innovation Congress in Riyadh yesterday, Sep 12th, 2018. He was invited to give a special address on the topic of LEADING INNOVATION IN HEALTHCARE.